ADIPOQ and type 2 diabetes mellitus: Although adequate pediatric reference intervals for fetuin-A and adiponectin still need to be established, several large case-cohort studies conducted on the adult population have shown their link to the development of obesity-related comorbidities, such as T2DM and cardiovascular disease [21,22,23].